RespireRx Pharmaceuticals Inc (RSPI)

[Xtremetz1]

Double edge sword. If it goes to human trials and has immediate success over 12 to 24 months of several stages of human trials. It may lead to numerous other big pharmaceutical companies to take notice resulting in a bidding war. If they grab it over the next year based on these results and further results in the testing cycle. A company could save itself a half a billion to a billion dollars. The other complication is no one knows for sure what the results look like because they don’t have to share them with anyone. If an interested company steps forward. They will undoubtedly be entering in to an NDA. The public won’t know anything until the rumor hits the street and the stock will begin to take off. One of the biggest signs is the expansion of the application for further testing. If that gets approved then the ship will have left the harbor for the regular investors.